Drug-Resistant Pulmonary Tuberculosis

Resistance to medication is not a traditional Chinese medicine (TCM) concept. Drug-resistant pulmonary tuberculosis is entirely unfamiliar within the framework of traditional Chinese medicine. It refers essentially to cases in which the causative microorganisms are resistant to currently used Western antituberculosis drugs. However, this patient group is characterized by difficulty achieving a cure and may also be classified under the concept of “difficult-to-treat pulmonary tuberculosis.” This concept is not unfamiliar within the TCM system; it encompasses a range of pathophysiological features and patterns in this patient group, and places greater emphasis on the disease and its treatment itself—not solely on the causative microorganisms. In TCM diagnosis and treatment, these patients are still classified under “feilao” (pulmonary consumption) or “laobing” (consumptive disease). However, when differentiating patterns and selecting treatment, greater consideration should be given to the pathophysiological changes associated with drug resistance and difficulty treating the disease—that is, the distinctive TCM disease mechanisms and patterns.

TCM Pattern Differentiation and Medication Reference

|Common Symptoms

Clinical description:

The disease course is relatively short, and patients are often in generally good health with a strong immune-inflammatory response. Common accompanying symptoms include tidal fever, night sweats, and increased sputum production.

In plain language:

  • The illness began relatively recently
  • Generally good health before becoming ill
  • A strong response to infection, which may include episodes of fever
  • Night sweats
  • More sputum, with a noticeable increase in the amount coughed up

|Treatment Approach

Clinical description:

Clear the lungs and address consumptive disease; nourish yin and reduce deficient heat.

In plain language:

  • In TCM, this approach is intended to clear lung inflammation and pathogenic factors, ease persistent cough, low-grade fever, night sweats, coughing up blood, and other symptoms associated with physical depletion, and help manage the condition
  • Nourish body fluids and reduce “deficient heat” to ease dry mouth and throat and heat in the palms and soles, and support recovery of strength

|Related Products

The products below are provided for information only and do not constitute medical advice or a prescription. Refer to the product packaging and instructions, and use under the guidance of a doctor or pharmacist.

|Common Symptoms

Clinical description:

The disease has usually been present for many years, with substantial physical depletion or pre-existing poor health. Common accompanying symptoms include shortness of breath, sweating easily with activity, fatigue, and weakness.

In plain language:

  • The illness has lasted a long time, causing physical depletion, or the person was already in relatively poor health
  • Shortness of breath or a feeling of not getting enough air
  • Sweating with even light activity
  • Easy fatigue and lack of strength

|Treatment Approach

Clinical description:

Support qi and nourish yin; regulate and tonify the lungs and kidneys.

In plain language:

  • In TCM, this approach is intended to support vitality and nourish body fluids, easing fatigue, dry mouth and throat, night sweats, feelings of heat, and other discomforts
  • It also aims to regulate lung and kidney function and ease persistent cough, shortness of breath, frequent colds, soreness and weakness in the lower back and knees, feeling cold, or frequent nighttime urination, while supporting respiratory endurance and recovery

|Related Products

The products below are provided for information only and do not constitute medical advice or a prescription. Refer to the product packaging and instructions, and use under the guidance of a doctor or pharmacist.

|Common Symptoms

Clinical description:

The disease has lasted for years or decades, causing severe physical depletion and often accompanying organ dysfunction. Common symptoms include extreme weight loss, shortness of breath, aversion to cold, spontaneous sweating, profound fatigue and listlessness, and a pale complexion.

In plain language:

  • The illness has persisted for many years, causing severe physical depletion
  • There may also be reduced function of organs such as the heart, lungs, or kidneys
  • Marked weight loss and a visibly thin appearance
  • Shortness of breath or easy breathlessness
  • Feeling cold and sweating with even slight activity
  • Severe fatigue and low energy
  • Pale complexion

|Treatment Approach

Clinical description:

Nourish yin and clear heat; tonify the kidneys and support the lungs.

In plain language:

  • In TCM, this approach is intended to nourish body fluids and clear “internal heat,” easing dry mouth and throat, restlessness and feeling hot, afternoon tidal fever, night sweats, and other discomforts
  • It also aims to support kidney and lung qi and ease persistent cough, shortness of breath, frequent colds, soreness and weakness in the lower back and knees, feeling cold, or frequent nighttime urination, while supporting stamina and respiratory function

|Related Products

The products below are provided for information only and do not constitute medical advice or a prescription. Refer to the product packaging and instructions, and use under the guidance of a doctor or pharmacist.

References

  1. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China[J]. N Engl J Med，2012，366(23)：2161-2170.
  2. Ministry of Health of the People’s Republic of China. National Baseline Survey Report on Drug Resistance in Tuberculosis (2007–2008)[R]. Beijing: People’s Medical Publishing House, 2010.
  3. Technical Guidance Group for the Fifth National Tuberculosis Epidemiological Sample Survey. Report on the Fifth National Tuberculosis Epidemiological Sample Survey, 2010[J]. Chinese Journal of Antituberculosis，2012，34(8)：485-508.
  4. Peng Weisheng, Wang Yingnian, Xiao Chengzhi. New Edition of Tuberculosis[M]. Beijing: China Medical Science Press, 2003：551-553.
  5. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis: Emergency update 2008[R]. Geneva：WHO，2008：50-79.
  6. Chinese Medical Association. Clinical Guidelines for Diagnosis and Treatment: Tuberculosis[M]. Beijing: People’s Medical Publishing House, 2005：64-86.
  7. Ministry of Health of the People’s Republic of China. Guiding Principles for Clinical Research on New Traditional Chinese Medicines (Series 1)[M]. Beijing: People’s Medical Publishing House, 1993.
  8. Chinese Medical Association, Tuberculosis Branch. Guidelines for the Diagnosis and Treatment of Pulmonary Tuberculosis[J]. Chinese Journal of Tuberculosis and Respiratory Diseases，2001，24(2)：70-74.
  9. Chinese Antituberculosis Association. Guidelines for the Chemotherapy of Drug-Resistant Tuberculosis (2009)[J]. Chinese Journal of Antituberculosis，2010，32(4)：181-198.
  10. Chen Wanyu. Analysis of the efficacy of Compound Liujü Tablets in the treatment of newly treated smear-positive pulmonary tuberculosis[J]. Modern Hospital，2006，6(3)：32-33.
  11. Chen Wanyu. Observation of the efficacy of chemotherapy combined with Compound Liujü Tablets in the treatment of newly treated smear-positive pulmonary tuberculosis[J]. Medical Information，2006，19(8)：1409-1411.
  12. Fan Li. Observation of the efficacy of Antil tuberculosis Pills combined with chemotherapy in the treatment of pulmonary tuberculosis[J]. Chinese Community Physician (Medical Edition)，2013，13(3)：214-215.
  13. Li Xiaodong, Zhou Hongyu, Li Zhiwei, et al. Observation of the efficacy of short-course chemotherapy plus Feitai Capsules for pulmonary tuberculosis[J]. Journal of Clinical Pulmonary Medicine，2012，17(11)：2040-2041.
  14. Yang Xiaolin. Clinical observation of Baidi Ziyin Pills combined with antituberculosis drugs in the treatment of pulmonary tuberculosis[J]. Inner Mongolia Journal of Traditional Chinese Medicine，2005，23(2)：21-24.
  15. Li Yonghong. Analysis of the clinical effects of Jianpi Runfei Pills as adjunctive treatment for difficult-to-treat pulmonary tuberculosis[J]. Chinese Journal of Modern Drug Application，2011，5(7)：94-95.
  16. Dai Lijuan, Zhao Limin, Wei Pingjuan. Clinical evaluation of Gulaodi Injection as adjunctive treatment in newly treated patients with smear-positive pulmonary tuberculosis[J]. Heilongjiang Medicine and Pharmacy，2003，1：72.
  17. Li Shuxia, Wen Xiaojun. Observation of the efficacy and nursing care of 61 cases of minor hemoptysis due to pulmonary tuberculosis treated with Pulmonary Tuberculosis Pills[J]. Medical Journal of National Defending Forces in Southwest China，2009，7：730-731.
  18. Shi Liqiu. Observation of the efficacy of Jiehelin Tablets in 68 patients with retreatment pulmonary tuberculosis[J]. Journal of Liaoning Medical University，2011，3：246-247.
  19. Chen Hongwei, Wang Tingyan, Yang Jianhua, et al. Clinical analysis of Maozhaocao Capsules for the treatment of cervical lymph node tuberculosis in patients with diabetes[J]. Journal of Practical Diagnosis and Therapy，2004，2：107-108.